Americas Cancer Immunotherapy Market HighlightsThe Americas Cancer Immunotherapy industry is projected to grow from USD 100.54 Billion in 2024 to USD 118.27 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 15.32% during the forecast period (2024 - 2032).Cancer Immunotherapy is an advanced paradigm in cancer therapeutics. Cancer immunotherapy works by enhancing the patient’s im..